Sagard's Third Private Credit Fund Just Hit $1 Billion. Here's What It Means for Direct Lending

Sagard just closed the first tranche of its third direct-lending fund at more than $1 billion, according to Alternative Credit Investor. The Canadian alternative asset manager pulled commitments from 16 institutional limited partners for Sagard Credit Partners III (SCP III), which is targeting $2 billion total, and the fund has already put $135 million to work across three transactions, per Pulse 2.0. If you've been watching institutional money pile into private credit over the past 18 months, this raise fits the pattern. But the details matter more than the headline number, and I want to walk through what's actually happening here before you draw conclusions about what it means for the asset class.

What Sagard Actually Does With Your Money

Sagard Credit Partners lends directly to mid-market companies in the US and Canada instead of buying loans on the secondary market or waiting for a bank syndicate to originate a deal. That's the core of "direct lending": the fund's own team sources, underwrites, negotiates, and holds the loan on its books, cutting out the investment bank that would normally arrange a syndicated loan and sell pieces of it to a crowd of buyers. The borrower gets a single lender who can move fast and structure the deal around its business; the fund gets to set its own terms, price the risk itself, and collect the full spread instead of splitting it with an underwriting syndicate.

SCP III's loans are also "senior secured," the part of the capital stack you want to own if things go wrong. Senior means the fund gets paid back before subordinated lenders, mezzanine holders, and equity investors in a bankruptcy or restructuring. Secured means the loan is backed by specific collateral (receivables, inventory, equipment, sometimes real estate) that the lender can seize and sell if the borrower stops paying.

One detail in Sagard's own materials matters more than the topline number: the strategy targets non-sponsored borrowers, meaning companies that aren't owned or backed by a private equity firm. That's a real distinction. Most direct-lending mega-funds (think Ares, Blackstone, Blue Owl) hunt for sponsor-backed deals, where a PE firm has already done its own diligence, will inject equity if the company stumbles, and brings repeat deal flow. Lending to a non-sponsored, privately owned business means Sagard is doing all of that diligence itself, with no PE sponsor standing behind the company as a backstop. Sagard frames this as "an underserved segment of the credit market," and it probably is. But underserved usually means harder to underwrite, not just less competitive.

The fund's target is $2 billion, so a $1 billion first close means Sagard is roughly halfway to goal, with more closes expected before the fund locks. Deployment so far, $135 million across three deals, tells you two things: LPs are willing to commit capital before it's fully put to work, which is normal for a drawdown fund, and the actual investment track record on SCP III itself is, at this point, three data points.

The Predecessor Funds Set the Bar

SCP III is following a real pattern, not a first attempt. Sagard Credit Partners II closed at $1.17 billion in June 2022 and has since deployed 100% of its committed capital across a diversified portfolio, according to both source reports. That's a meaningful signal on its own. A fund that's fully invested and, implicitly, generating cash flow for its LPs is a fund a manager can point to when raising the next vintage. Across SCP I and II combined, Sagard says it has deployed more than $1.9 billion of capital with 29 realizations to date, meaning 29 loans that have been paid off, refinanced, or otherwise exited. And zooming out further, Sagard's broader credit platform, which includes strategies beyond the SCP series, has deployed approximately $4.5 billion since the platform launched in 2016.

That track record is the entire pitch to LPs. Nobody commits $1 billion to a blind pool because they like the logo. They commit because the prior fund did what it said it would do, and the team running SCP III is largely the same team, led by Adam Vigna, Sagard's co-founder and chief investment officer.

Why Institutional Money Is Still Chasing Private Credit in Mid-2026

Direct lending fundraising has been on a genuine tear this year. According to industry tracking of H1 2026 closed-end private credit fundraising, managers raised roughly $262 billion in the first half of the year, up about 30% from a year earlier, with nearly 70% of that coming in the second quarter alone. Direct lending specifically is "back": five of the ten largest fund closes in the period were direct-lending vehicles. Law firm tracking from DLA Piper's Q2 2026 Private Credit Pulse found North American direct-lending funds raised at least $16 billion from institutional investors in Q2 alone, the second-strongest quarter in four years for the category.

Why does this money keep showing up? Yield, mostly. Morgan Stanley's private credit team has estimated asset yields on directly originated first-lien loans (the most senior slice of the loan, first to get paid) will trough around 8.0% to 8.5% in 2026 even after some spread compression, still elevated by historical standards. Pension funds, insurers, and sovereign wealth funds facing long-dated liabilities have concluded an 8%-plus yield on senior secured paper, even if illiquid, beats what they can get from investment-grade bonds. Direct lending also gives an LP exposure to floating-rate income (the loan's interest rate resets periodically with a benchmark rate) without the daily price swings of a bond portfolio, because these loans aren't traded on an exchange and are typically valued quarterly by the manager.

There's also a structural story underneath the LP demand. Research cited in ABF Journal's analysis of mega-fund growth shows the average leveraged buyout deal size within direct lending jumped to roughly $380 million in 2025, up from about $200 million in 2020, as the largest platforms grow so big they can only write large checks efficiently. That pushes the biggest managers upmarket, toward deals resembling the broadly syndicated loan market, while leaving the lower and core middle market, companies with $10 million to $100 million of EBITDA, comparatively less crowded. Sagard's non-sponsored, mid-market focus sits in exactly that gap: a real niche, not just marketing language, and one reason a $1 billion to $2 billion fund can still find LP demand even as $10 billion-plus mega-funds dominate the fundraising headlines.

The Part of the Story Nobody Puts in the Press Release

Now the caution. A $1 billion first close with $135 million deployed across three investments is, mathematically, a fund that is roughly 13.5% invested against its first close and less than 7% invested against its ultimate $2 billion target. That's normal for a drawdown structure early in its life. LPs commit capital that gets called down over a multi-year investment period, so a low deployment ratio at first close isn't a red flag by itself. But it does mean anyone evaluating SCP III today is evaluating a track record, not a fund. The actual assets inside SCP III are three loans, and you have no idea yet how those borrowers will perform through a full credit cycle. You won't have a real read on manager skill in this vintage until the fund is substantially deployed and has weathered at least one stress period.

This is where private credit's structural quirks matter more than most retail-facing coverage acknowledges.

Concentration risk is real in the early innings. With only a handful of positions on the books, one bad loan can do outsized damage to early-vintage returns. A syndicated leveraged loan fund or a public high-yield bond fund holds dozens to hundreds of names and can absorb a default without much portfolio-level damage. A direct lender with three loans cannot. That risk fades as the fund scales toward its target, assuming Sagard maintains underwriting discipline as it deploys, which is a real assumption, not a given.

Marks are the manager's opinion, not a market price. Because these loans don't trade on an exchange, the fund's net asset value rests on the manager's own valuation process, typically reviewed quarterly, sometimes with a third-party valuation firm involved. That's standard practice, but it means an LP is trusting Sagard's internal marks in a way a public bond investor never has to. If a borrower is struggling, there's often a lag between the business deteriorating and the fund's reported value reflecting it.

Floating-rate loans cut both ways. Floating-rate income was a gift to direct lenders when the Federal Reserve held rates high through 2023 and 2024, and LPs collected fatter coupons as base rates stayed elevated. But the same mechanism works in reverse on borrowers: a mid-market company carrying floating-rate debt through a high-rate stretch sees its interest expense rise in lockstep, squeezing the cash flow available to service that debt. That's part of why Morgan Stanley's credit team flagged healthcare loans as leading all sectors in loans placed on non-accrual status (meaning the borrower has effectively stopped making scheduled payments) over the past year. Rates cutting from here would ease pressure on borrowers but would also compress the yield Sagard's LPs are underwriting to. There's no scenario where rate moves are a non-event for a portfolio built entirely on floating-rate loans.

Non-sponsored means no equity backstop. This deserves a second look through the risk lens. When a PE-sponsored borrower hits a rough patch, the sponsor often has both the incentive and the capital to inject fresh equity, which indirectly protects the lender too. A non-sponsored, privately owned mid-market company doesn't have that safety net. If the owner-operator's business slows down, Sagard's underwriting and collateral package is the only protection the fund has, with no PE firm standing by to write a rescue check. That's the source of the "illiquidity premium" Sagard charges for, and also why the underwriting quality of the GP (general partner, meaning the fund manager) matters more here than in a sponsor-backed strategy.

Illiquidity is the price of admission, not a footnote. This is a drawdown fund. Once you commit, your capital is locked up for years, typically a fund life of seven to ten years including extensions, with no ability to redeem on demand the way you could sell out of a mutual fund or ETF. If a credit downturn hits in year three, you can't get out. You ride it out, alongside every other LP, on whatever terms the fund's governing documents allow.

A Due-Diligence Checklist If You're Evaluating a Fund Like This

Most AIN readers won't be writing a check into an institutional-minimum vehicle like SCP III directly. Minimums and accreditation requirements put funds like this out of reach for most individual investors, though these strategies increasingly show up wrapped inside semi-liquid interval funds or BDCs (business development companies) sold to wealth clients. Whether you're looking at Sagard, a competing direct lender, or the private credit sleeve inside a wealth-management product, the diligence questions are the same:

• Track record across a full cycle, not just a good stretch. Ask how the manager's prior funds performed through 2020 and through the 2022-2023 rate-hike shock, not just since rates started easing. A fund with data only from a benign credit environment hasn't been tested.
• Realized returns versus unrealized marks. Distinguish between capital the manager has actually returned to LPs through realizations (loans paid off, refinanced, or exited) and capital still marked at the manager's own estimated value on paper. Sagard citing 29 realizations across SCP I and II is a genuinely useful data point. Be skeptical of a fund that can only point to unrealized marks.
• Fee structure and how it's calculated. Private credit funds typically charge a management fee (often 1% to 1.5% of committed or invested capital) plus a performance fee or "carry" (commonly 15% to 20% of profits above a hurdle rate, typically 6% to 8%). Ask whether fees are charged on committed or invested capital. The difference matters a lot when a fund is only 13% deployed.
• Deployment discipline versus deployment pressure. A manager sitting on a large first close has an incentive to deploy capital quickly to start earning fees and show LPs progress. Ask whether it has ever paused when it didn't see attractive deals. A willingness to sit on dry powder beats a manager who always finds a way to deploy on schedule.
• Concentration limits and sector caps. Ask what share of the fund can go into a single borrower, industry, or geography. Sagard's cross-border Canada/US mandate and non-sponsored focus are differentiators, but they're also concentration factors worth quantifying.
• Covenant quality on the actual loans. Ask whether the fund's loans carry maintenance covenants (financial tests the borrower must meet on an ongoing basis) or are covenant-lite, where the lender only acts once the borrower actually misses a payment. Covenant-lite terms have become more common industry-wide in large sponsor-backed deals; a manager focused on smaller, non-sponsored borrowers should generally have more covenant protection, not less. Ask them to confirm it.

The first close of SCP III tells you private credit's institutional demand hasn't cooled off, and it tells you Sagard has a real, multi-vintage track record to point to. It doesn't yet tell you how the third fund's three loans will perform, and it won't for years. That's not a knock on Sagard specifically — it's the nature of the asset class. Anyone selling you a private credit allocation on the strength of a first-close press release is selling you the fundraise, not the returns. Judge the manager on realizations, not commitments.

Author Disclosure: Jeff Barnes, MBA has no personal position in any company, fund, or platform named in this article. Angel Investors Network has no current commercial relationship with any party mentioned. AIN provides marketing and education services, not investment advice. Past performance does not guarantee future results. All investments involve risk, including loss of principal.